| Date | Title | Description |
| 29.03.2021 | Cell-Easy strengthens executive team with two new highly exp... | Jérôme Bédier joins as Chief Operating Officer and Guillaume Lay as Global Business Development Mana... |
| 08.03.2021 | Focus on Merieux Equity Partners' upcoming fifth investment ... | The Fund will be dedicated to Growth & Buyout, with a target of € 500M.
(article in Les Echos)... |
| 08.03.2021 | Focus on Merieux Equity Partners and their upcoming fifth in... | This Fund will be dedicated to Growth & Buyout, with a target of € 500M. |
| 02.03.2021 | SERB completes acquisition of BTG Specialty Pharmaceuticals | This acquisition transforms the group into a global leader and a fully integrated specialty pharmace... |
| 18.02.2021 | AcuSurgical raises €5.75 M in Series A financing, to advance... | The company will use the proceeds of the Series A financing to conduct clinical trials and reach reg... |
| 12.01.2021 | MERIEUX EQUITY PARTNERS ACQUIRES MAJORITY STAKE IN PLANTEX, ... | Plantex is a French manufacturer of high quality natural plant extracts for nutraceutical, dietary, ... |
| 21.12.2020 | ELSAN has entered into exclusive discussions with C2S Group ... | This operation would enable Elsan and C2S to become the number one private healthcare operator in Fr... |
| 10.12.2020 | Merieux Equity Partners invests in Laboratoires CTRS alongsi... | CTRS is a French pharmaceutical company that develops and markets treatments for patients with stron... |
| 08.12.2020 | Cell-Easy announces the completion of a financing round to a... | Cell-Easy is a stem cell Contract Development and Manufacturing Organization (CDMO) that provides re... |
| 30.11.2020 | BIOBEST acquires ownership of Beneficial Insectary Inc. of C... | Beneficial Insectary Inc. is North America's largest independent producer of beneficial insects and ... |
| 24.11.2020 | CEVA becomes first animal health company to be awarded "... | Two products were approved by the Welfare Scheme - Velactis and Ketofen. |
| 19.11.2020 | SEQENS invests in new technologies and is committed to produ... | To carry out these projects, Seqens relies on the SEQENS’Lab, its R&D center, and on four of its... |
| 09.11.2020 | XERIS PHARMACEUTICALS REPORTS THIRD QUARTER 2020 FINANCIAL R... | Gvoke® net sales grew 370% quarter over quarter to $9.4 million driven by launch of Gvoke HypoPen®.... |
| 23.10.2020 | ProDigest and Biofortis announce an agreement for a global c... | This Agreement will enable a combination of the know-how in preclinical testing developed by ProDige... |
| 29.09.2020 | keepMED completes €13 M Series C financing round and advance... | keepMED has designed and developed keePAP® - a unique, responsive and personalized positive airway p... |
| 29.09.2020 | CEVA BUILDS ON ITS PREVENTATIVE HEALTH STRATEGY WITH OPENING... | This €8 million innovative project confirms Ceva’s commitment to improving preventative animal healt... |
| 28.08.2020 | SEQENS inaugurates an innovative HPAPI unit at its Villeneuv... | The site was inaugurated in the presence of Emmanuel Macron, President of the French Republic and Br... |
| 10.08.2020 | XERIS PHARMACEUTICALS REPORTS SECOND QUARTER 2020 FINANCIAL ... | Gvoke® net sales were $2.0 million in Q2 2020. Gvoke PFS prescriptions grew 72% quarter over quarter... |
| 28.07.2020 | TARA Biosystems and VantAI Partner to Accelerate Cardiac Dru... | VantAI and TARA Biosystems today announced the launch of a biology-driven, AI-enabled collaboration.... |
| 22.07.2020 | MRM Health appoints Dr. Werner Cautreels as Chairman and Dr.... | Dr. Werner Cautreels, former CEO of Solvay Pharmaceuticals and Selecta Biosciences, has been appoint... |
| 07.07.2020 | TARA Biosystems Report Study Results Demonstrating In Vitro ... | Appearing in the Journal of Pharmacological and Toxicological Methods, these findings further suppor... |
| 07.05.2020 | Mérieux Equity Partners and Korys announce the launch of OMX... | The new investment platform in Venture Capital will support innovative companies in the healthcare a... |
| 09.04.2020 | L'Entreprise des Possibles is Mobilizing Businesses to help ... | First results and sollicitating sponsorships, partnerships and donations. |
| 19.03.2020 | Seqens is fully mobilized to guarantee the safety and health... | Seqens will keep providing active ingredients and pharmaceutical intermediates such as paracetamol a... |
| 19.03.2020 | Nutragroup is fully mobilized to first guarantee the safety ... | Nutragroup will keep delivering particular vitamins and immuno-stimulants to their customers (Food S... |
| 12.03.2020 | CEVA Santé Animale returns to strong double-digit growth in ... | Consolidated sales of the Ceva Group reached more than €1.2 billion in 2019. |
| 04.02.2020 | Ceva Santé Animale reorganizes its shareholding structure, w... | - |
| 15.01.2020 | Twist Bioscience Selected as DNA Synthesis Provider for DNA ... | - |
| 13.01.2020 | Twist Bioscience Promotes Patrick Weiss to Chief Operating O... | Twist Bioscience also announces the appointment of Bill Banyai, Ph.D., as Senior Vice President of A... |
| 08.01.2020 | MERIEUX EQUITY PARTNERS SUCCESSFULLY COMPLETES THE FUNDRAISI... | Mérieux Equity Partners announces the closing of the fundraising for Mérieux Participations 3, new i... |
| 07.01.2020 | Genome editors begin lining up for Inscripta’s Onyx Digital ... | - |
| 06.01.2020 | XERIS PHARMACEUTICALS ANNOUNCES POSITIVE RESULTS FROM THE IN... | Results show that a mini dose of Ready-To-Use (RTU) Glucagon was adequate to maintain normal blood g... |
| 12.12.2019 | Protéus by Seqens launches SEQENZYM®, Enzyme Kits selected a... | The easy-to-use enzyme kits can accelerate screening of enzymes for molecules synthesis transformati... |
| 11.12.2019 | Twist Bioscience and Pandion Therapeutics Expand Antibody Op... | Pandion is developing modular biologics and antibodies for autoimmune regulation that are designed t... |
| 11.12.2019 | Twist Bioscience Reports Fourth Quarter and Full Year Fiscal... | Fiscal 2019 Revenues Increase 114% over Fiscal 2018 to $54.4M. Continued Strength in Synthetic Biolo... |
| 11.12.2019 | Mérieux Equity Partners becomes reference shareholder of Add... | - |
| 10.12.2019 | Inscripta Raises $125M in Series D Financing | New funding brings total amount raised to $259.5M and will be used to accelerate commercialization o... |
| 10.12.2019 | XERIS PHARMACEUTICALS ANNOUNCES POSITIVE TOPLINE RESULTS FRO... | All subjects - at risk of postprandial hypoglycemia following bariatric surgery - successfully self-... |
| 26.11.2019 | Merieux Equity Partners co-invests alongside IK Investment P... | Mabtech's products are used by researchers and companies worldwide to study immune responses in canc... |
| 22.11.2019 | PhysioAssist announces that the multicentric MUCOSIM clinica... | The objective of this prospective randomized trial is to compare the efficacy and safety of the inno... |
| 20.11.2019 | Twist Bioscience Promotes Patrick J. Finn to Chief Commercia... | Dr. Finn, Ph.D., previously served as senior vice president of commercial operations and will now be... |
| 08.11.2019 | Ivantis Announces 3 Year Results of Australian SPECTRUM Regi... | SPECTRUM is a post market patient registry for the Hydrus® Microstent, a microinvasive glaucoma surg... |
| 08.11.2019 | Twist Biopharma Implements Genedata Biologics to Advance Syn... | Twist Biopharma, a division of Twist Bioscience, has adopted Genedata Biologics® to support their R&... |
| 07.11.2019 | XERIS PHARMACEUTICALS REPORTS THIRD QUARTER 2019 FINANCIAL R... | Gvoke™ (glucagon injection) pre-filled syringe is now available by prescription. MAA for ready-to-us... |
| 05.11.2019 | SGH Healthcaring unveils a new asthma spacer device, at CPHI... | A revolutionary new design that improves drug administration and simplifies treatment delivery for b... |
| 30.10.2019 | Twist Bioscience to Provide Target Enrichment Products for M... | Under the terms of the non-exclusive co-marketing agreement, MGI - a subsidiary of global genomics l... |
| 30.10.2019 | SEQENS SPS increases the capacity of its isopropyl acetate u... | Based on an innovative process, with a reactive distillation and a high energy efficiency, this prod... |
| 25.10.2019 | Twist Bioscience Appoints Seasoned Life Sciences Industry Ex... | Mr. Barthelemy brings extensive experience, both as an operational executive and board member, in th... |
| 24.10.2019 | Biobest further strengthens their technical team by hiring M... | Mr Zuijderwijk will be responsible for the Technical Biocontrol Strategy. In addition, he and his te... |
| 10.10.2019 | Ivantis Completes Enrollment of International SPECTRUM Regis... | Largest Single-Device Ophthalmic Registry Includes Nearly 3,000 Eyes with 700+ Stand-Alone Glaucoma ... |
| 04.10.2019 | Focus on Mérieux Equity Partners in Private Equity Magazine | article in French |
| 01.10.2019 | SuperSonic Imagine innovates in ultrasound with its new live... | This new diagnostic approach in ultrasound is made possible thanks to the new generation of UltraFas... |
| 01.10.2019 | CEVA AND PROBIOGEN SIGN AN EXCLUSIVE LICENSE AGREEMENT TO PR... | ProBioGen and Ceva have a long track record of producing innovative veterinary vaccine technologies ... |
| 01.10.2019 | Xeris Pharmaceuticals Appoints Mark Thierer to Board of Dire... | Mr. Thierer has a demonstrated track record of successful financial and operational strategy through... |
| 01.10.2019 | Inscripta Launches the World’s First Benchtop Platform for D... | The Onyx™ platform enables scientists to create libraries of millions of precisely engineered single... |
| 01.10.2019 | Twist Bioscience Showcases New Innovation Lab at SynBioBeta ... | Innovation Lab is a program designed to translate customer needs into new, disruptive products facil... |
| 24.09.2019 | European Respiratory Society Study: Chronic Obstructive Pulm... | The WHO (2004) report is indisputable: chronic obstructive pulmonary disease will become the third l... |
| 19.09.2019 | XERIS PHARMACEUTICALS BEGINS DOSING PATIENTS IN A PHASE 2 CL... | The XeriSol™ technology allows for simultaneous concentration and stabilization of insulin and praml... |
| 13.09.2019 | Amplitude, partner of the X-Pulse Project | The X-Pulse project aims to build a prototype of pre-clinical imaging system, based on x-ray sources... |
| 10.09.2019 | XERIS PHARMACEUTICALS RECEIVES U.S. FDA APPROVAL FOR GVOKE™ ... | GVOKE is the first premixed, prefilled, premeasured liquid glucagon offering ease of use for severe ... |
| 10.09.2019 | KERANOVA RAISES €24M IN SECOND ROUND OF FINANCING | Funds will enable company to finalize regulatory process with view to obtaining CE mark for ultra-fa... |
| 10.09.2019 | CEVA PARTNERS WITH BIOTECON DIAGNOSTICS TO INTRODUCE A REAL-... | The highly-sensitive test, using DNA, will detect and differentiate accurately between the vaccine s... |
| 05.09.2019 | Inscripta Appoints Jim Lalonde to Lead Microbial Digital Gen... | Dr. Lalonde has spent more than 25 years in research and development leadership, overseeing signific... |
| 04.09.2019 | Seqens Cosmetics obtains Ecovadis’ gold certification for Co... | Seqens Cosmetics rank in the top 4% of companies assessed in the industry. |
| 29.08.2019 | Inscripta Expands Management Team with Appointment of Three ... | Inscripta today announced the appointment of Deanna Church, Ph.D., Simon Cawley, Ph.D., and Nandini ... |
| 29.07.2019 | Twist Bioscience launches Long Oligos to fuel drug developme... | At up to 300 bases, or nucleotides, in length this is the longest commercial oligo offering by conti... |
| 03.07.2019 | CEVA COMPLETES ACQUISITION OF IDT VETERINARY BUSINESS ASSETS... | Ceva and IDT have successfully completed the acquisition of IDT’s veterinary biopharmaceutical and R... |
| 21.06.2019 | SuperSonic Imagine announces that it has received a binding ... | Hologic is planning to acquire a controlling stake of approximately 46% of the Company’s capital. |
| 18.06.2019 | Seqens is unveiling its main innovation and development cent... | SEQENS'Lab is a 34,000 sqm science platform and centre of excellence for developing a totally unique... |
| 17.06.2019 | Xeris Pharmaceuticals Announces Additional Positive Outcomes... | Findings will support application for European marketing authorization and augment body of data supp... |
| 31.05.2019 | Dr Jan Ohrstrom takes on Executive Leadership of BIOM'UP | Dr Ohrstrom has been Chairman of the Board of Directors since 2015. |
| 23.05.2019 | Twist Bioscience Strengthens Board With Semiconductor and St... | Mr Chan, former CEO of Magellan, brings over 35 years of experience as both a director and operation... |
| 17.05.2019 | CEVA SANTE ANIMALE AND IDT BIOLOGIKA GMBH ANNOUNCE AGREEMENT | CEVA to acquire the IDT Animal Health business, expanding its global vaccine portfolio and boosting ... |
| 07.05.2019 | SGH Healthcaring - An original primary packaging range for n... | Having recently acquired Eskiss Packaging, the group now offers a wide range of primary packagaing f... |
| 02.05.2019 | Ivantis announces groundbreaking 3 year results from FDA cli... | First device in Minimally Invasive Glaucoma Surgical (MIGS) category to demonstrate significant long... |
| 01.05.2019 | Xeris Pharmaceuticals Announces Results From a Phase 1 Study... | Favorable pharmacokinetic, safety, and tolerability results support continued development of Xeris' ... |
| 30.04.2019 | Inscripta Appoints Ron McGrath as Chief Financial Officer | Mr. McGrath has held leadership and financial roles for over 25 years in the biotechnology and infor... |
| 08.04.2019 | Mérieux Equity Partners teams up with ICG to acquire leading... | DOC Generici is Italy’s largest independent generic pharmaceutical company. |
| 04.04.2019 | Inscripta Completes $20M Expansion of Series C Financing, In... | Continued support of existing investors will fund commercialization efforts, product launch later th... |
| 28.03.2019 | Merieux Equity Partners to enter in exclusive negotiations f... | Amplitude Laser Group has transformed itself into a global leader with a truly international footpri... |
| 25.03.2019 | Xeris Pharmaceuticals presents new Clinical and Economic Imp... | Data from a Phase 2 study in congenital hyperinsulinism (CHI) reinforce the utility of Xeris’ ready-... |
| 20.03.2019 | Seqens strengthens its cosmetics and healthcare offering wit... | ID bio is a producer of natural ingredients for cosmetics and H2B is a manufacturer of fractionated ... |
| 15.03.2019 | LNA Santé acquires the Moulin Vert Rehabilitation Center | The Moulin Vert facility specializes in the treatment of respiratory diseases and heart disorders |
| 15.03.2019 | Xeris Pharmaceuticals doses first patient in Phase 2 trial e... | Xeris has begun dosing Type 1 diabetes patients with its stable liquid Glucagon. |
| 14.03.2019 | Biobest's PMV®-01: First Vaccine against PepMV authorized in... | PMV®-01 is the first plant vaccine against Pepino Mosaic Virus (PepMV) in tomato authorized by EPA a... |
| 14.03.2019 | Ivantis announces 24-month results of Landmark Clinical Tria... | International multi-center study compares effectiveness of the Hydrus® Microstent to two Glaukos iSt... |
| 13.03.2019 | Amplitude launches the Satsuma Display | Satsuma Display is the most compact air-cooled femtosecond laser on the market, offering 4 individua... |
| 11.03.2019 | SGH Healthcaring acquires Eskiss Packaging and Dosapharm Lab... | The French designer and manufacturer of innovative medical devices - formerly known as Stiplastics -... |
| 25.01.2019 | SEQENS' R&D Center in Porcheville, France obtains its GM... | This confirms Porcheville's status as a center of excellence for the development and industrializati... |
| 17.01.2019 | Benoit Chastaing joins Mérieux Equity Partners as Senior Par... | Benoit will foster the firm’s growth capital, MBO/LBO and majority investment activities. |
| 15.01.2019 | Mérieux Equity Partners has acquired a majority stake in Nut... | The acquisition was made via Mérieux Participations 3 - third generation fund dedicated to fast-grow... |
| 24.12.2018 | Biobest and Australian company Bugs for Bugs team up through... | BIOBEST expands in Australia |
| 21.12.2018 | Novacap becomes Seqens | SEQENS. A new name for a global leader in pharmaceutical synthesis and specialty ingredients. |
| 19.12.2018 | Inscripta's MAD7 CRISPR Enzyme is widely adopted by the Gene... | Existing investors contribute an additional $30 million to accelerate tools that will revolutionize ... |
| 31.10.2018 | Twist Bioscience completes a successful IPO on the Nasdaq | TWIST BIOSCIENCE writes a new chapter along its extraordinary growth trajectory |
| 24.10.2018 | TWIST Bioscience adds Ray Tabibiazar, M.D., as Senior Vice P... | Dr Tabibiazar has also been appointed acting General Manager of the Division focused on biologics dr... |
| 23.10.2018 | Xeris Pharmaceuticals Announces FDA Acceptance for Review of... | Xeris Pharmaceuticals Announces FDA Acceptance for Review of NDA for Its Ready-to-Use Glucagon Rescu... |
| 06.09.2018 | Biom'up surpasses 200 surgeons | Biom'up surpasses 200 surgeons trained in the United States and Europe in anticipation of the launch... |
| 06.09.2018 | Mérieux Développement invests €20 million in Biobest, with t... | Mérieux Développement invests €20 million in Biobest, with the aim of establishing the company as a ... |
| 06.09.2018 | SuperSonic Imagine Reports 11% + Revenue Growth | SuperSonic Imagine Reports 11% + Revenue Growth in Q1 2018 (+ 20% at Constant Currencies) |
